Literature DB >> 6149770

Smokers need higher doses of neuroleptic drugs.

E Vinarová, O Vinar, Z Kalvach.   

Abstract

There is indirect evidence that smoking induces higher enzymatic activity which accelerates the metabolism of many drugs. This influence is inferred from the frequency and magnitude of drug side effects. We could demonstrate that smokers need higher doses of neuroleptic drugs than nonsmokers.

Mesh：

Substances：

Year:  1984        PMID： 6149770

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


  10 in total

1.  Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.

Authors:  Roland Berecz; Alfredo de la Rubia; Pedro Dorado; Pedro Fernández-Salguero; Marja-Liisa Dahl; Adrián LLerena
Journal:  Eur J Clin Pharmacol       Date:  2003-03-28       Impact factor: 2.953

Review 2.  Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.

Authors:  H D Desai; J Seabolt; M W Jann
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities.

Authors:  Taryn G Moss; Andrea H Weinberger; Jennifer C Vessicchio; Vincenza Mancuso; Sandra J Cushing; Michael Pett; Kate Kitchen; Peter Selby; Tony P George
Journal:  Am J Addict       Date:  2010 Jul-Aug

4.  Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance.

Authors:  M W Jann; S R Saklad; L Ereshefsky; A L Richards; C A Harrington; C M Davis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.

Authors:  M H Joseph; S L Peters; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Patient reactions to a no smoking policy in a community mental health center.

Authors:  R D Maiuro; M C Michael; P P Vitaliano; J A Chiles; P M Davis
Journal:  Community Ment Health J       Date:  1989

Review 7.  Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment.

Authors:  P Glue; R P Clement
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

8.  Effects of an adenosine A2A agonist on the rewarding associative properties of nicotine and neural plasticity in a rodent model of schizophrenia.

Authors:  Wesley Drew Gill; Heath W Shelton; Katherine C Burgess; Russell W Brown
Journal:  J Psychopharmacol       Date:  2019-11-07       Impact factor: 4.562

9.  Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF.

Authors:  Wesley Drew Gill; Katherine C Burgess; Cynthia Vied; Russell W Brown
Journal:  J Psychopharmacol       Date:  2021-07-22       Impact factor: 4.562

10.  Admission to a psychiatric unit and changes in tobacco smoking.

Authors:  Suzy Ker; David Owens
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-05-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.